Exactly right. Prurisol has been a drag on the company for a long while. I’m glad this phase is over and the company can focus on its huge success with B. Leo’s stated strategy of doing phase 2 trials of Brilacidin to develop its platform potential is turning out to be a very smart decision. Bertolino no doubt deserves credit as well.
News 
Market Data 
Discover 
